Shree Ganesh Bio-Tech (India) Limited has submitted to the Exchange a Statement of Investor Complaints for the quarter ended September 30, 2022 under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Attachment :- 221006_SHREEGANES_AN_01.pdf
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Shree Ganesh BioTech India Ltd. published this content on 06 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 October 2022 10:41:06 UTC.